Babraham Bioscience Technologies (United Kingdom)

Recent papers from Babraham Bioscience Technologies (United Kingdom)

1. Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protectionImmunity · 2026
2. Multimodal gene and targeted drug therapy for chronic myelogenous leukemia using BIM/MCL-1 chimeric nanoparticle: computational target analysis and therapeutic validationNano Convergence · 2026
3. SPROUTS_DB: An Implemented Database of Contaminants for Extracellular Vesicle Proteomics StudiesPROTEOMICS · 2026
4. Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UKnpj Vaccines · 2026
5. A microwave-assisted method to recycle Nb ₂ O ₅ -based materials used in Li-ion battery anodesJournal of Materials Chemistry A · 2026
6. Mechanistic insights into the monotherapy and combination potential of FEN1 inhibition in cancer therapyNucleic Acids Research · 2025
7. MAPPs assays for non-clinical immunogenicity risk assessment: best practices recommended by the European immunogenicity platformFrontiers in Immunology · 2025
8. Safety and immunogenicity of a single booster dose of the group B streptococcus AlpN candidate vaccine (GBS-AlpN) in previously vaccinated healthy women compared with a single dose in previously unvaccinated womenVaccine · 2025
9. Intranasal delivery of mRNA expressing newly identified Acinetobacter baumannii antigens protects against bacterial lung diseasenpj Vaccines · 2025
10. Drug treatment alters performance in a neural microphysiological system of information processingCommunications Biology · 2025
11. SPROUTS_DB: an implemented database of contaminants for extracellular vesicle proteomics studies2025
12. Drug treatment alters performance in a neural microphysiological system of information processing2025
13. The genetic architecture of HIV-1 virulenceVirus Evolution · 2025
14. CpGPT: a Foundation Model for DNA Methylation2024
15. Discovery of reversible and covalent TEAD 1 selective inhibitors MSC-1254 and MSC-5046 based on one scaffoldBioorganic & Medicinal Chemistry Letters · 2024
16. Genome-wide CRISPR/Cas9 screen shows that loss of GET4 increases mitochondria-endoplasmic reticulum contact sites and is neuroprotectiveCell Death and Disease · 2024
17. DNA methylases for site-selective inhibition of type IIS restriction enzyme activityApplied Microbiology and Biotechnology · 2024
18. Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolutionMolecular Neurodegeneration · 2024
19. A human anti-matriptase-2 antibody limits iron overload, α-globin aggregates, and splenomegaly in β-thalassemic miceBlood Advances · 2024
20. Molecular determinants of cross-reactivity and potency by VH3-33 antibodies against the Plasmodium falciparum circumsporozoite proteinCell Reports · 2023